A facile synthesis of novel monocyclic trans-and cis-3-oxy/thio/seleno-4-pyrazolyl-β-lactams (5, 6) is described. The reaction of 2-methoxy/phenoxy/benzyl/phenylthio/seleno ethanoic acids or acetoxyacetyl chloride 4 with pyrazolyl substituted Schiff′s bases 3a-d using POCl 3 and Et 3 N in refluxing toluene furnished β-lactams (5, 6). These synthesized β-lactams have been characterized by spectroscopic techniques viz. NMR ( 1 H, 13 C and 77 Se), FT-IR, mass
Introduction
β-Lactam heterocyclic compounds have been reported as synthons for the synthesis of amino acids, alkaloids and taxoids 1 and successfully used for medicinal applications, such as cholesterol acyl transferase inhibitors, thrombin inhibitors, human cytomegalovirus protease inhibitors, matrix-metallo protease inhibitors, human leukocyte elastase inhibitors, cysteine protease inhibitors, apoptosis inductors, gene activators, and β-turn nucleators. 2 The biological activity usually associated with the nature of the groups linked to N-1, C-3 and C-4 of the β-lactam molecules. Therefore, the construction of novel pyrazole substituted β-lactams with control of functionality, stereochemistry and regioselectivity has remained a great challenge for the synthetic organic chemist in order to enhance their spectrum of biological activity, potency and specificity.
Pyrazole substituted heterocycles have a wide range of applications in agrochemicals, medicine and the pharmaceutical industry. 3,4-Disubstituted pyrazole derivatives have been shown to exhibit cyclin dependent kinase inhibitory activity and inhibited in vitro cellular proliferation in various human cells. 3 A series of pyrazole derivatives have been showing high antiproliferative and antiangiogenic activities against human breast (MCF-7) and cervical carcinoma cells. [4] [5] [6] Identification of antitumor activity of pyrazole oxime ethers has been well documented. 7 Bonesi et al. 8 synthesized a substituted pyrazole and investigated their potential activity as inhibitors of angiotensin coverting enzyme (ACE). In literature, several reports have demonstrated substituted pyrazole and their derivatives as inhibitors of GSK3β Glycogen synthase kinase, 9 VEGFR2 kinase, 10 tyrosinase, 11 phagocytosis of opsonized blood cells 12 and arylamine N-acetyltransferase. 13 Bondock et al., 14 Radi et al., 15 Sahu et al., 16 Barsoum et al. 17 and Burguete et al. 18 have synthesized a series of substituted pyrazole and their derivatives possess antifungal, antimicrobial, antibacterial and anti-inflammatory activities. 4,5-Disubstituted pyrazoles have been shown to exhibit potent antiviral activity against a broad panel of viruses in different cell cultures (HEL Cell cultures) including hepatitis A virus and Herpes simplex virus type-I. 19, 20 Antidepressant and anticonvulsant activity of pyrazole derivatives has been reported by Abdel Aziz et al. 21 The recent success of pyrazole derivatives as acyclonucleoside analogues, 15 blockers of divalent metal transporter 1 (DMT1) 22 and COX-2 inhibitors 23 has further highlighted the importance of this heterocyclic ring. 3-Methoxy-β-lactams have been found to have apoptotic activity against human leukemia, breast, prostate and head-neck cancer cells, thus exhibiting antitumor activity. 24 3-Acetoxy/phenoxy-β-lactams serve as the precursors to taxol, taxotere (highly promising anticancer drugs). 25 3-Benzyl/phenylthio/seleno-β-lactams have been reported to be synthons of biologically important heterocycles. 26 Encouraged by the broad spectrum of biological activity of pyrazole derivatives and β-lactams, it was planned to incorporate the pyrazolyl moiety into suitably substituted β-lactams to furnish novel pyrazole substituted β-lactam heterocycles. In literature, very few reports are available for the synthesis of such type of molecules. Buttero et al. 27 have prepared 4-(pyrazol-4/5-yl)carbonyl-2-azetidinones via nitrilimine cycloaddition.
Parmar et al. 28 have prepared β-lactams based on N-phenyl-3-phenyl-4-formyl pyrazole (PEP).
Banik et al. 29 have recently reported the iodine/bismuth catalyzed synthesis of pyrrole substituted spirocyclic-β-lactams, 2,34,40 (Z)-and (E)-3-allylidene-β-lactams, 41 3-keto-β-lactams 42 and bicyclic-β-lactams. 43 Herein, we report the synthesis of novel monocyclic trans-and cis-3-oxy/thio/seleno-4-pyrazolyl-β-lactams (5, 6).
Results and Discussion
The study began with the chloropyrazolecarbaldehyde 2, prepared from the pyrazolinone 1 following a literature procedure 44 (Scheme 1). The pyrazole-substituted Schiff′s bases 3a-d were prepared by stirring equivalent amounts of an appropriate primary amine with the aldehyde 2 using molecular sieves (4Å) in dichloromethane (Scheme 1, Table 1 ). and elemental analysis.
The synthesis of novel trans-and cis-3-oxy/thio/seleno-4-pyrazolyl-β-lactams 5-6 has been achieved via Staudinger cycloaddition between the Schiff′s bases 3a-d and a ketene generated from 2-substituted ethanoic acids or acid chloride 4, respectively (Scheme 2).
Initially, 2-(phenylthio)ethanoic acid was reacted with Schiff′s base 3a using phosphorus oxychloride (POCl 3 ) and triethylamine (Et 3 N) in dry methylene chloride at 0 °C, but this reaction did not afford the desired product. However, when the reaction was performed in refluxing dry toluene and the progress of the reaction was monitored by thin-layer chromatography (TLC), it resulted in the exclusive formation of trans-3-phenylthio-4-pyrazolyl-β-lactam 5a in excellent yield (Scheme 2, Table 2 , Entry 1). The target product 5a was purified by column chromatography on silica gel using ethyl acetate-hexane (10:90) as eluant and was identified as Table 2 , entry 14, 19). However, 2-methoxyethanoic acid on treatment with Schiff′s bases 3a-c furnished trans-β-lactams 5o-q as the major isomers along with cis-β-lactams 6o-q as the minor isomers, respectively (Scheme 2, Table 2 , Entry 15-17). All these newly synthesized monocyclic trans-and cis-3-oxy/thio/seleno-4-pyrazolyl-β-lactams (5, 6) were purified by column chromatography on silica gel using ethyl acetate-hexane (10:90) as the eluant.
The structures of these trans-and cis-3-oxy/thio/seleno-4-pyrazolyl-β-lactams (5, 6) were established on the basis of various spectroscopic techniques viz., FTIR, NMR ( 1 H, 13 C, 77 Se), mass spectrometry (EI-MS and HRMS) and their elemental analysis (solid β-lactams only). The IR absorption band in the range 1724-1755 cm -1 for the C=O of the β-lactam ring supported the formation of pyrazolyl-β-lactams 5, 6. The spatial juxtaposition of the C3-H and C4-H was assigned trans and cis in products 5, 6 on the basis of coupling constant values (J = 1.2-2.7 Hz and J = 4.5-5.1 Hz C3-H and C4-H), respectively in the 1 H NMR spectra. 35, 39 The stereochemistry at C-3 and C-4 of β-lactams 5, 6 was established through single crystal X-ray crystallographic studies of 5p ( Figure 1 ). 45 In the EIMS spectrum of trans-3-methoxy-4-pyrazolyl-β-lactam 5p, a peak corresponding to the fragment [M+Na] + with low intensity confirmed the formation of the target product. The base peak does not correspond to the molecular ion peak and appears at m/z 420. . CHN elemental analysis of the solid β-lactams (5d, 5f, 5l, 5m, 6n, 6p, 6s) and the HRMS analysis of β-lactams (5a, 5b, 5c, 5e, 5g, 5h, 5i, 5j, 5k, 5o, 5q, 5r, 6o and 6q) further confirmed the formation of the target products. The trans-and cis-3-oxy/thio/seleno-4-pyrazolyl-β-lactams 5, 6 are air-and moisture-stable, soluble in solvents such as dichloromethane, chloroform, acetone, toluene and ethyl acetate. trans-4-Pyrazolyl-β-lactams 5d, 5f, 5l, 5m, 5p and cis-4-pyrazolyl-β-lactams 6n, 6p, 6s were obtained as stable solids while the rest were obtained as yellowish brown oils. Scheme 3. Plausible mechanism for synthesis of 3-oxy/thio/seleno-4-pyrazolyl-β-lactams 5, 6.
All these cycloaddition reactions were found to be highly stereoselective and indicate that the presence of different groups in the substrate moieties effect the stereochemical outcome of the desired pyrazolyl-β-lactams. The plausible mechanism for the formation of trans-and cis-β-lactams having a variety of substitutions at the C-3 position is depicted in Scheme 3. The synthesis of pyrazolyl-β-lactams proceeds with the generation of ketene A by treatment of 2-methoxy-/phenoxy/benzyl/phenylthio/phenylseleno ethanoic acids or acetoxyacetyl chloride 4 with phosphorus oxychloride and triethylamine in refluxing toluene. Further, the nucleophilic attack of the imino nitrogen of the E-imine on the face of the ketene A (RX = C 6 H 5 O, C 6 H 5 S, C 6 H 5 Se, C 6 H 5 CH 2 S, C 6 H 5 CH 2 Se CH 3 O, CH 3 COO) generating the zwitterionic intermediate B and C respectively, which on direct ring closure or conrotatory electrocyclization afforded the stereoselective trans-and cis-3-oxy/thio/seleno-4-pyrazolyl-β-lactams (5, 6).
The plausible mechanism included above is in accordance with our earlier publication of stereoselective synthesis of cis-and trans-3-alkoxy-β-lactams, 39 where mechanistic aspects were discussed in detail with relevance to reports available in the literature. [48] [49] [50] In the present work, all the 2-benzyl/phenylthio/seleno ethanoic acids (Moore ketenes having S/Se-alkyl or aryl groups) on treatment with pyrazolyl substituted imines gives trans-β-lactams as suggested in the literature. [48] [49] [50] Whereas, the Bose-Evans ketenes (having O-alkyl or O-aryl groups) should give cis-β-lactams, which have been achieved in the synthesis of cis-3-methoxy/acetoxy-β-lactams with low yield. However, this cycloaddition did not afford the targeted products at lower temperature, therefore high temperature selectively favors the formation of predominantly trans-β-lactams. Further, competition between the rate of isomerisation and direct ring closure, temperature and substituents plays an important role towards the stereoselectivity of these Staudinger cycloadditions which is well documented in literature. 39, [48] [49] [50] The crystal structure of trans-1-(4′-methoxyphenyl)-3-methoxy-4-(5′-chloro-3′-methyl-1′-phenyl-1H-pyrazol-4′-yl)azetidin-2-one 5p was established by X-ray crystallographic analysis (Figure 1) . 45 It was crystallized from dichloromethane-hexane (3:1) as a colorless crystalline solid suitable for single crystal X-ray diffraction. A perspective view of the molecular structure with atom numbering has been given in Figure 1 . (Figure 2 , Table 3 ). In comparison to hydrogen bonding, quite weak intermolecular C-H interactions are also present.
Representatives of all these new trans-and cis-3-oxy/thio/seleno-4-pyrazolyl-β-lactams (5, 6) have been submitted for Molecular Docking studies to examine their binding affinities/interactions which will be followed by in vitro screening of the best fit molecules for their bioactivities such as antibacterial, antitumor, antiviral and antimicrobial activity. Further elaboration of the pyrazole substituted β-lactams (5, 6) to potential spirocyclic and bicyclic-β-lactams is underway in our laboratory.
Conclusions
In conclusion, a successful attempt has been made towards the synthesis of novel monocyclic trans-and cis-3-oxy/thio/seleno-4-pyrazolyl-β-lactams. Substrate scope was also investigated by varying the R, R 1 and X groups R = C 6 H 5 , C 6 H 5 CH 2 , CH 3 , CH 3 CO; X = O, S, Se; R 1 = C 6 H 5, CH 2 C 6 H 5 , 4-OCH 3 C 6 H 4 , 4-ClC 6 H 4 . The X-ray crystallographic analysis of compound 5p allowed the stereochemistry at C-3 of trans-β-lactams 5 to be established.
Experimental Section
General. Melting points were determined in an open capillary on melting point apparatus Perfit GSI-MP-3. Fourier transform infrared spectra were recorded on a Thermo Scientific Nicolet iS50 (FTIR) spectrophotometer (ν max in cm -1 ). 1 H (300 MHz), 13 C (75 MHz) and 77 Se (57 MHz) NMR spectra were recorded on JEOL AL 300 (300 MHz) spectrometer. Chemical shifts are given in ppm relative to Me 4 Si as an internal standard (δ = 0 ppm) for 1 H NMR, CDCl 3 (δ = 77.0 ppm) for 13 C NMR spectra and Me 2 Se (δ = 0 ppm) for 77 Se NMR spectra. The mass spectra (EI-MS and HRMS) were obtained using a Waters Q-TOF Micromass (YB361) spectrometer (permissible % error = 5-10 ppm). The elemental analysis (C, H, N) were recorded on Flash 2000 Organic elemental analyzer. Column chromatography was performed using Merck silica gel (60-120 mesh) using ethyl acetate-hexanes (10:90) as eluant system. Reactions were monitored by analytical thin-layer chromatography (TLC) using Merck silica gel G using ethyl acetate-hexanes (10:90) as an eluant system. For visualization, TLC plates were stained with iodine vapors or observed under UV light. The reactions for the preparation of pyrazole substituted β-lactams were carried out under dry and deoxygenated nitrogen atmosphere. Phosphorus oxychloride (Merck), triethylamine (Qualigen), ethyl acetoacetate (Merck), phenylhydrazine (Hi-media) and all other commercially available compounds/reagents/solvents were of reagent grade quality and used without any further purification. Dimethylformamide and dichloromethane were dried and distilled over anhydrous calcium chloride (CaCl 2 ) and phosphorus pentoxide (P 2 O 5 ) respectively. Toluene was distilled under N 2 from sodium-benzophenone immediately before use. Starting materials pyrazolone 1 and pyrazolecarbaldehyde 2 were prepared following the methods described in literature. 44 The Typical procedure for the preparation of Schiff's bases 3a-d. A solution of the appropriate primary amine (1 mmol) and 5-chloro-3-methyl-1-phenyl-1H-pyrazole-4-carbaldehyde (1 mmol) in the presence of molecular sieves (4 Å) in dry methylene chloride (15 ml) was stirred at room temperature. The progress of the reaction was monitored by TLC. After completion of the reaction, the reaction mixture was filtered to remove the molecular sieves and the solvent was evaporated under vacuum to yield the imine, which was recrystallized from methylene chloride: hexane to afford a crystalline solid. The organic layer was washed with water (3 × 10 ml), 1N HCl (3 × 10 ml), 5% NaHCO 3 (3 × 10 ml) and brine (3 × 10 ml), then dried (Na 2 SO 4 ) and concentrated. The residue was purified by silica gel column chromatography with hexane/EtOAc (90:10) as eluant to afford pure products. 1-(4′-chlorophenyl)-3-phenylthio-4-(5′-chloro-3′-methyl-1′-phenyl-1H-pyrazol-4′-yl) -1-Phenyl-3-benzylthio-4-(5′-chloro-3′-methyl-1′-phenyl-1H-pyrazol-4′-yl) Benzyl-3-phenoxy-4-(5′-chloro-3′-methyl-1′-phenyl-1H-pyrazol-4′-yl)-azetidin-2-one (6n) 
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